I’d buy these FTSE 100 stocks while share prices are low

With FTSE 100 (INDEXFTSE: UKX) shares prices down significantly this year, many opportunities are emerging for long-term investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Every stock market crash provides opportunities for long-term investors. This crash is likely to be no different. With FTSE 100 share prices down significantly this year, many compelling opportunities are emerging.

Of course, in the short term, the FTSE 100 could fall further. No one knows what’s going to happen tomorrow, or next week. However, in the long run, the stock market should recover.

With that in mind, here’s a look at three FTSE 100 stocks I’d snap up while share prices are low.

FTSE 100 champion

One stock I’d buy is Unilever (LSE: ULVR). It’s a consumer goods company that owns a powerful portfolio of trusted brands, including Dove and Domestos.

Unilever appears to be a classic Warren Buffett-type stock. For a start, its brands provide a strong competitive advantage. Secondly, it’s able to generate relatively consistent earnings throughout the economic cycle. Third, it’s highly profitable, generating a return of 20%+ on every euro invested. And finally, it has a superb long-term track record.

ULVR shares have held up well in the recent stock market crash, as I expected. However, I wouldn’t be surprised to see near-term share price weakness if the FTSE 100 falls further. I’d view any such frailty as a buying opportunity.

Healthcare giant

Another FTSE 100 share I’d buy while the market is down is GlaxoSmithKline (LSE: GSK). It’s a healthcare giant that specialises in pharmaceuticals, vaccines, and consumer healthcare products.

The reason I like GSK is that it appears well-placed to benefit from a number of dominant structural trends in the years ahead. Firstly, there’s the world’s ageing population. This is likely to mean increased demand for healthcare. Then, there’s the rise in wealth across the emerging markets. As wealth rises, so does healthcare spending. Finally, there’s the increasing prevalence of diseases, such as chronic obstructive pulmonary disease (the second most common lung disease in the UK after asthma).

I also like the fact that GSK operates in a defensive sector. No matter the state of the economy, people are still likely to need medication and healthcare products.

GSK shares were trading near 1,800p at the start of the year, yet today are significantly cheaper. I’d take advantage of this share price weakness and buy for the long term.

Dominant trend

Finally, another FTSE 100 stock I’d buy while share prices are low is JD Sports Fashion (LSE: JD). I like JD because it’s a play on one of the most dominant trends in the clothing industry today – athleisure.

Throughout the world, demand for the sports casualwear/fitness crossover has skyrocketed in recent years. And this trend looks set to continue. In 2018, the athleisure market was valued at $155bn. Yet by 2026, it’s forecast to be worth $257bn. That’s an annualised growth rate of 7% per year. “The adoption of the athleisure trend is here to stay and it’s going to accelerate,” says Adam Goldenberg, CEO of fashion retailer TechStyle Fashion Group.

Of course, JD’s sales are likely to take a hit in the near term. Its stores are closed, and discretionary income is likely to fall. However, the FTSE 100 company’s share price has fallen a long way this year, meaning a lot of risk is priced in.

Under 500p, I think the stock offers great value.

Edward Sheldon owns shares in Unilever, GlaxoSmithKline and JD Sports Fashion. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

£10,000 invested in Tesla stock 1 month ago is now worth…

Dr James Fox takes a closer look at Tesla stock as it trades around an all-time high valuation. Is there…

Read more »

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Recently released: December’s lower-risk, higher-yield Share Advisor recommendation [PREMIUM PICKS]

Ice ideas will usually offer a steadier flow of income and is likely to be a slower-moving but more stable…

Read more »

Sunrise over Earth
Investing Articles

Meet the ex-penny share up 109% that has topped Rolls-Royce and Nvidia in 2025

The share price of this investment trust has gone from pennies to above £1 over the past couple of years.…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

1 of the FTSE 100’s most reliable dividend stocks for me to buy now?

With most dividend stocks with 6.5% yields, there's a problem with the underlying business. But LondonMetric Property is a rare…

Read more »

Investing Articles

Is 2026 the year to consider buying oil stocks?

The time to buy cyclical stocks is when they're out of fashion with investors. And that looks to be the…

Read more »

ISA coins
Investing Articles

3 reasons I’m skipping a Cash ISA in 2026

Putting money into a Cash ISA can feel safe. But in 2026 and beyond, that comfort could come at a…

Read more »

US Stock

I asked ChatGPT if the Tesla share price could outperform Nvidia in 2026, with this result!

Jon Smith considers the performance of the Tesla share price against Nvidia stock and compares his view for next year…

Read more »

Investing Articles

Greggs: is this FTSE 250 stock about to crash again in 2026?

After this FTSE 250 stock crashed in 2025, our writer wonders if it will do the same in 2026. Or…

Read more »